Precision Medicine for Sng/Pain Control

Plain-language summary

This study examined pain treatments such as low-level laser, therapeutic ultrasound and local dextrose injection (prolotherapy) in patients with myofascial pain syndrome. It enrolled patients aged 20-100 who had this diagnosis and agreed to treatment. This study has no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

National Taiwan University Hospital

Intervention

LASER, A.therapeutic ultrasound group, B.prolotherapy group

Start date

8/28/2021

Estimated completion

11/30/2023

Countries

Taiwan

Related genes

Locations

• Taipei, Taiwan

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* (1) Age between 20-100 years old.
* (2) Diagnosed as myofascial pain syndrome patients and willing to receive treatment (including LLLT, therapeutic ultrasound, and local dextrose injection therapy).

Exclusion Criteria:

* Those having active infection, malignancy, and hematological diseases were excluded. The patients had received local injection at upper trapezius within 3 months are also excluded.